{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:11:43Z","timestamp":1789143103181,"version":"build-2803163510"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,22]]},"DOI":"10.7759\/cureus.88534","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T17:52:11Z","timestamp":1753206731000},"source":"Crossref","is-referenced-by-count":1,"title":["Predictive Factors of Autologous Bone Marrow-Derived Mesenchymal Stem Cell Therapy\u2019s Success in the Treatment of Perianal Fistulas in Patients With Crohn\u2019s Disease"],"prefix":"10.7759","author":[{"given":"Sofia","family":"Oubaha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oussama","family":"Nacir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imane","family":"Zouaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadija","family":"Krati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/bs.apha.2024.10.013","article-title":"Current and emerging therapeutic strategies for perianal fistula in Crohn's disease patients","volume":"101","author":"Ding K","year":"2024","unstructured":"Ding K, Kong J, Li L, Selaru FM, Parian A, Mao HQ. Current and emerging therapeutic strategies for perianal fistula in Crohn's disease patients. Adv Pharmacol. 2024, 101:159-82. 10.1016\/bs.apha.2024.10.013","journal-title":"Adv Pharmacol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s10151-019-02024-8","article-title":"Mesenchymal stem-cell therapy for perianal fistulas in Crohn's disease: a systematic review and meta-analysis","volume":"23","author":"Cheng F","year":"2019","unstructured":"Cheng F, Huang Z, Li Z. Mesenchymal stem-cell therapy for perianal fistulas in Crohn's disease: a systematic review and meta-analysis. Tech Coloproctol. 2019, 23:613-23. 10.1007\/s10151-019-02024-8","journal-title":"Tech Coloproctol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-025-04272-y","article-title":"Efficacy of mesenchymal stem cell-based therapies in the treatment of perianal fistulizing Crohn's disease: a systematic review and meta-analysis","volume":"16","author":"Guillo L","year":"2025","unstructured":"Guillo L, Gravier Dumonceau R, V\u00e9lier M, Serrero M, Grimaud F, Sabatier F, Magalon J. Efficacy of mesenchymal stem cell-based therapies in the treatment of perianal fistulizing Crohn's disease: a systematic review and meta-analysis. Stem Cell Res Ther. 2025, 16:152. 10.1186\/s13287-025-04272-y","journal-title":"Stem Cell Res Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-024-03637-z","article-title":"Efficacy and safety of stem cell therapy for Crohn's disease: a meta-analysis of randomized controlled trials","volume":"15","author":"Qiu Y","year":"2024","unstructured":"Qiu Y, Li C, Sheng S. Efficacy and safety of stem cell therapy for Crohn's disease: a meta-analysis of randomized controlled trials. Stem Cell Res Ther. 2024, 15:28. 10.1186\/s13287-024-03637-z","journal-title":"Stem Cell Res Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.214841","article-title":"Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease","volume":"60","author":"Ciccocioppo R","year":"2011","unstructured":"Ciccocioppo R, Bernardo ME, Sgarella A, et al.. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease. Gut. 2011, 60:788-98. 10.1136\/gut.2010.214841","journal-title":"Gut"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.22074\/cellj.2022.7981","article-title":"Mesenchymal stromal cell therapy improves refractory perianal fistula in Crohn\u2019s disease: case series clinical interventional study","volume":"24","author":"Vosough M","year":"2022","unstructured":"Vosough M, Nikfam S, Torabi SH, et al.. Mesenchymal stromal cell therapy improves refractory perianal fistula in Crohn\u2019s disease: case series clinical interventional study. Cell J. 2022, 24:62-8. 10.22074\/cellj.2022.7981","journal-title":"Cell J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31203-X","article-title":"Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn\u2019s disease: a phase 3 randomised, double-blind controlled trial","volume":"388","author":"Pan\u00e9s J","year":"2016","unstructured":"Pan\u00e9s J, Garc\u00eda-Olmo D, Van Assche G, et al.. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn\u2019s disease: a phase 3 randomised, double-blind controlled trial. Lancet. 2016, 388:1281-90. 10.1016\/S0140-6736(16)31203-X","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izab361","article-title":"INSPECT: a retrospective study to evaluate long-term effectiveness and safety of darvadstrocel in patients with perianal fistulizing Crohn's disease treated in the ADMIRE-CD trial","volume":"28","author":"Pan\u00e9s J","year":"2022","unstructured":"Pan\u00e9s J, Bouma G, Ferrante M, et al.. INSPECT: a retrospective study to evaluate long-term effectiveness and safety of darvadstrocel in patients with perianal fistulizing Crohn's disease treated in the ADMIRE-CD trial. Inflamm Bowel Dis. 2022, 28:1737-45. 10.1093\/ibd\/izab361","journal-title":"Inflamm Bowel Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0000000000002325","article-title":"Follow-up study to evaluate the long-term safety and efficacy of darvadstrocel (mesenchymal stem cell treatment) in patients with perianal fistulizing Crohn's disease: ADMIRE-CD phase 3 randomized controlled trial","volume":"65","author":"Garcia-Olmo D","year":"2022","unstructured":"Garcia-Olmo D, Gilaberte I, Binek M, et al.. Follow-up study to evaluate the long-term safety and efficacy of darvadstrocel (mesenchymal stem cell treatment) in patients with perianal fistulizing Crohn's disease: ADMIRE-CD phase 3 randomized controlled trial. Dis Colon Rectum. 2022, 65:713-20. 10.1097\/DCR.0000000000002325","journal-title":"Dis Colon Rectum"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-024-03746-9","article-title":"A phase I\/II clinical trial of ex-vivo expanded human bone marrow derived allogeneic mesenchymal stromal cells in adult patients with perianal fistulizing Crohn's Disease","volume":"15","author":"Swaroop S","year":"2024","unstructured":"Swaroop S, Vuyyuru SK, Kante B, et al.. A phase I\/II clinical trial of ex-vivo expanded human bone marrow derived allogeneic mesenchymal stromal cells in adult patients with perianal fistulizing Crohn's Disease. Stem Cell Res Ther. 2024, 15:140. 10.1186\/s13287-024-03746-9","journal-title":"Stem Cell Res Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.06.014","article-title":"Allogeneic bone marrow-derived mesenchymal stromal cells promote healing of refractory perianal fistulas in patients with Crohn\u2019s disease","volume":"149","author":"Molendijk I","year":"2015","unstructured":"Molendijk I, Bonsing BA, Roelofs H, et al.. Allogeneic bone marrow-derived mesenchymal stromal cells promote healing of refractory perianal fistulas in patients with Crohn\u2019s disease. Gastroenterology. 2015, 149:918-27.e6. 10.1053\/j.gastro.2015.06.014","journal-title":"Gastroenterology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-023-03331-6","article-title":"Mesenchymal stem cells transplantation for perianal fistulas: a systematic review and meta-analysis of clinical trials","volume":"14","author":"Wang H","year":"2023","unstructured":"Wang H, Jiang HY, Zhang YX, Jin HY, Fei BY, Jiang JL. Mesenchymal stem cells transplantation for perianal fistulas: a systematic review and meta-analysis of clinical trials. Stem Cell Res Ther. 2023, 14:103. 10.1186\/s13287-023-03331-6","journal-title":"Stem Cell Res Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/364286-predictive-factors-of-autologous-bone-marrow-derived-mesenchymal-stem-cell-therapys-success-in-the-treatment-of-perianal-fistulas-in-patients-with-crohns-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T17:52:12Z","timestamp":1753206732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/364286-predictive-factors-of-autologous-bone-marrow-derived-mesenchymal-stem-cell-therapys-success-in-the-treatment-of-perianal-fistulas-in-patients-with-crohns-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.88534","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,22]]}}}